We are live on ! Find out more
DCI

Data Collective IV Portfolio holdings

AUM $55.9M
1-Year Est. Return 49.14%
This Fund
S&P 500
This Quarter Est. Return
-2.96%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
-$5.55M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 52.21%
2 Industrials 47.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.62B
$59.2M 51.36%
5,941,120
EVLV icon
2
Evolv Technologies
EVLV
$1.01B
$43.1M 37.35%
9,681,281
RKLB icon
3
Rocket Lab Corp
RKLB
$39.9B
$12M 10.44%
2,929,350
DFTX
4
Definium Therapeutics
DFTX
$5.57B
$943K 0.82%
100,350
ROIV icon
5
Roivant Sciences
ROIV
$24.3B
$40.8K 0.04%
3,875

Similar funds

Data Collective IV's Q1 2024 Portfolio in Review

As of Q1 2024, Data Collective IV held 5 positions worth $115M, down 4.6% from $121M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. Data Collective IV opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Industrials.

  • Data Collective IV's ten largest holdings make up 100% of its $115M portfolio in Q1 2024.
  • Data Collective IV opened 0 new positions and closed 0 in Q1 2024.
  • Data Collective IV's portfolio value fell 4.6% quarter-over-quarter to $115M.

Based on Data Collective IV's 13F filing for Q1 2024, filed 15 May 2024.